---
title: Investigating ticagrelor in a preclinical pipeline as a novel therapeutic to
  prevent preterm birth
date: '2024-01-11'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38205973/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240111170708&v=2.18.0
source: heidelberg[Affiliation]
description: Preterm birth remains a significant global health challenge, affecting
  approximately 10% of pregnancies and resulting in one million deaths globally every
  year. Tocolytic agents, used to manage preterm labour, have considerable limitations
  including lack of efficacy, and adverse side-effects, emphasising the urgent need
  for innovative solutions. Here, we explore repurposing an antiplatelet cardioprotective
  drug, ticagrelor, as a potential treatment to prevent preterm birth. Ticagrelor
  ...
disable_comments: true
---
Preterm birth remains a significant global health challenge, affecting approximately 10% of pregnancies and resulting in one million deaths globally every year. Tocolytic agents, used to manage preterm labour, have considerable limitations including lack of efficacy, and adverse side-effects, emphasising the urgent need for innovative solutions. Here, we explore repurposing an antiplatelet cardioprotective drug, ticagrelor, as a potential treatment to prevent preterm birth. Ticagrelor ...